申请人:The Upjohn Company
公开号:US03972911A1
公开(公告)日:1976-08-03
It has now been discovered that novel compounds of FIG. 1 ##SPC1## are useful in the prophylactic treatment of sensitized humans and animals for allergy and all anaphylactic reactions of a reagin or non-reagin mediated nature. Additionally, these compounds are intermediates to the acids and physiologically acceptable salts which also have the same biological utility. The compounds of the invention are formulated with pharmaceutical carriers for oral, parenteral, inhalation or rectal means of administration.
现已发现,FIG.1的新化合物##SPC1##可用于预防治疗对变态反应原或非变态反应原介导的过敏和全身过敏反应的敏感人类和动物。此外,这些化合物是酸和生理上可接受的盐的中间体,这些酸和盐也具有相同的生物效用。本发明的化合物与制药载体配制,用于口服、注射、吸入或直肠给药方式。